Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Marsolais and LaFond not buyers

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Nov 09, 2023 12:25pm

71 Views

Post# 35726369

RE:RE:Marsolais and LaFond not buyers

The last thing this board is capable of is creating a buying frenzy and driving the price up. N one believes in the company. It's a show me results company now.

palinc2000 wrote:
My take is they are not privy to any data yet .Otherwise the CEO would not have bought based on undisclosed material info...
So if the CEO does not know it goes without saying that Marsolais is also in the dark
Lets say that Mardolais were to purchase a substantial number of shares .....say 50000 !!!
This MB would go bananas infering that Marsolais knows that results will be poditive and the SP would probably go up by 50% based on pure speculation...
I think they want to prevent creating a market frenzy based on thin air...
I see no other explanation

SPCEO1 wrote: I think these are the only two senior managers that I would have expected to buy shares like other insiders that did not do so.

I wonder if special accomodations have been made for these two who were blocked out for a very long time from exercising their long held options at levels that would have been profitable for them and this is why they did not participate in the recent buying? Their options are no longer in the money and will likely expire worthless if they have not done so already.

If THTX has done something to make them somewhat whole or at least give them a chance to get whole sometime in the future, that would be nice as they were trapped for the better part of a year without being able to exercise those options. I only wish the same could be done for legacy shareholders too!

If they have done something for those two I would like to know about it as otherwise the lack of joining in the buying by Marsolais, in particular, makes one wonder why.